Cited 9 times in
Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18-12
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.